MARSHALL WACE, LLP - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 127 filers reported holding ENDOLOGIX INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$85,000
-82.1%
118,383
-52.5%
0.00%
-50.0%
Q3 2018$476,000
-74.6%
249,458
-23.8%
0.00%
-83.3%
Q4 2016$1,872,000
+123.1%
327,301
+399.1%
0.01%
+100.0%
Q3 2016$839,000
-64.6%
65,576
-76.9%
0.01%
-73.9%
Q1 2016$2,373,000
+693.6%
283,797
+840.8%
0.02%
+666.7%
Q4 2015$299,000
+74.9%
30,167
+170.1%
0.00%
+50.0%
Q4 2014$171,00011,1700.00%
Other shareholders
ENDOLOGIX INC shareholders Q1 2015
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 1,121,447$2,142,0001.45%
Essex Woodlands Management, Inc. 1,257,468$6,684,0001.39%
Camber Capital Management LP 9,300,000$17,763,0000.76%
PFM Health Sciences, LP 7,408,585$14,150,0000.21%
NEA Management Company, LLC 2,490,204$4,756,0000.20%
ArrowMark Colorado Holdings LLC 10,276,145$19,627,0000.16%
Brown Capital Management 8,977,308$17,147,0000.16%
Partner Investment Management, L.P. 79,765$152,0000.12%
ALTRINSIC GLOBAL ADVISORS LLC 1,135,000$2,168,0000.10%
Lombard Odier Asset Management (USA) Corp 700,000$1,337,0000.10%
View complete list of ENDOLOGIX INC shareholders